Hubei Goto Biopharm Co.,Ltd. (300966.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.26B
Enterprise Value3.38B
P/E Ratio-36.61
PEG Ratio0.5
Price/Sales Ratio4.16
Price/Book Ratio2.92
Enterprise/Revenue5.98
Enterprise/EBITDA71.23

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.11
Operating Margin-0.16
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.08

Income Statement

Revenue606.18M
Revenue/Share5.9
Gross Profit83.5M
EBITDA57.93M
Net Income-73.36M
Diluted EPS-0.64

Balance Sheet

Total Cash75.48M
Total Cash/Share0.71
Total Debt1.22B
Total Debt/Equity1.47
Current Ratio0.99
Book Value Per Share8.54

Price History

52-Week Change-19.87
52-Week High32.58
52-Week Low18.44
Moving Average 50 Days26.69
Moving Average 200 Days23.09

Statistics

Average Volume5.31M
Shares Outstanding115.28M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.05
Trailing Annual Dividend Yield0.2
Payout Ratio-0.37
Last Split FactorN/A
Last Split DateN/A
AD